Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480–91. https://doi.org/10.1001/jama.2024.2315.

Article  CAS  PubMed  Google Scholar 

Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin N Am. 2014;40:51–60. https://doi.org/10.1016/j.rdc.2013.10.003.

Article  Google Scholar 

Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14:683–6. https://doi.org/10.1191/0961203305lu2200oa.

Article  CAS  PubMed  Google Scholar 

Rao RV, Chan KL. Systemic Lupus Erythematosus in: ASE’S Comprehensive Echocardiograhy, Second Edition, an imprint of Elsevier Inc. 2016:757–760.

Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum. 2013;43(1):77–95. https://doi.org/10.1016/j.semarthrit.2012.12.002.

Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc. 1999;74:275–284. https://doi.org/10.4065/74.3.275.

Crozier IG, Li E, Milne M, Gary Nicholls M. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol. 1990;65:1145–8.

Article  CAS  PubMed  Google Scholar 

Bourré-Tessier J, Huynh T, Clarke AE, Bernatsky S, Joseph L, Belisle P, Pineau CA. Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus. 2011;20(14):1518–25. https://doi.org/10.1177/0961203311420318.

Article  PubMed  Google Scholar 

Roldan CA, Qualls CR, Sopko KS, et al. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol. 2008;35:224–9.

Cauduro AS, Moder KG, Tsang TS, Seward JB. Clinical and echocardiographic characteristics of hemodynamically significant pericardial effusions in patients with systemic lupus erythematosus. Am J Cardiol. 2003;92:1370–1372. https://doi.org/10.1016/j.amjcard.2003.08.036.

Maharaj S, Chang S. Pericardial effusions in systemic lupus erythematosus — Who is most likely to develop tamponade? Int J Cardiol. 2015;180:149–150. https://doi.org/10.1016/j.ijcard.2014.11.191.

Bilal A, Sulemankhil I, Chauhan R. et al. “Breaking Muscles and Hearts”: Rhabdomyolysis and Pericardial Tampondate as Initial Manifestations of Systemic Lupus Erythematosuc. JACC. 2024;83(13_Supplement):3995. https://doi.org/10.1016/S0735-1097(24)05985-0.

Shalomi A, Ramesh R. Pericardial Effusion as the Initial Presentation of Systemic Lupus Erythematosus in a 37-Year-Old Female. Cureus. 2023;15(11):e49080. https://doi.org/10.7759/cureus.49080.

Creed K, Randhawa N, Siddiqui S, Wichmann A, Test V. Pericardial Effusion in a Middle Aged Woman as Initial Presentation of Systemic of Systemic Lupus Erythematous. CHEST. 160(4):A13. https://doi.org/10.1016/j.chest.2021.07.069.

Doherty N, Siegel R. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110:1257–65. https://doi.org/10.1016/0002-8703(85)90023-7.

Pieretti J. Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass. Circulation. 116(4). https://doi.org/10.1161/CIRCULATIONAHA.106.673319.

Gegenava T, Gegenava M, Steup-Beekman GM, Huizinga TWJ, Bax JJ, Delgado V, Marsan NA. Left ventricular systolic function in patients with systemic Lupus Erythematosus and its Association with Cardiovascular events. J Am Soc Echocardiogr. 2020;33(9):1116–22. https://doi.org/10.1016/j.echo.2020.04.018.

Article  PubMed  Google Scholar 

Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42(2):338–46.

Abbasi S, Tarter L, Farzaneh-Far R, Farzaneh-Far A. Hydroxychloroquine: a treatable cause of cardiomyopathy. J Am Coll Cardiol. 2012;60(8):786. https://doi.org/10.1016/j.jacc.2011.12.060.

Article  PubMed  Google Scholar 

Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med. 1988;319(13):817–23. https://doi.org/10.1056/NEJM198809293191302.

Article  CAS  PubMed  Google Scholar 

Moyssakis I, Tektonidou M, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos H. Libman-Sacks endocarditis in systemic Lupus Erythematosus: Prevalence, associations, and evolution. Am J Med. 2007;120(7):636–42. https://doi.org/10.1016/j.amjmed.2007.01.024.

Article  PubMed  Google Scholar 

Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992;20(5):1127–34. https://doi.org/10.1016/0735-1097(92)90368-w.

Article  CAS  PubMed  Google Scholar 

Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med. 1988;85(5):645–50. https://doi.org/10.1016/s0002-9343(88)80236-5.

Article  CAS  PubMed  Google Scholar 

Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335(19):1424–30. https://doi.org/10.1056/NEJM199611073351903.

Article  CAS  PubMed  Google Scholar 

Hussain K, Gauto-Mariotti E, Cattoni HM, Arif AW, Richardson C, Manadan A, Yadav N. A Meta-analysis and Systematic Review of Valvular Heart Disease in Systemic Lupus Erythematosus and Its Association with Antiphospholipid Antibodies. J Clin Rheumatol. 2021;27(8):e525-e532. https://doi.org/10.1097/RHU.0000000000001464.

Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480–91. https://doi.org/10.1001/jama.2024.2315. The clinical and immunological features crucial to the diagnosis of systemic lupus erythematosus are presented.

Rao RV, Chan KL. Systemic Lupus Erythematosus in: ASE’S Comprehensive Echocardiograhy, Second Edition, 2016, an imprint of Elsevier Inc. pp. 757–760. A comprehensive discussion. of systemic lupus erythematosus focusing on the cardiac manifestations and their prevalences.